STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis
Background and objectives Acute kidney injury (AKI) is one of the most common and severe clinical syndromes of diffuse proliferative lupus nephritis (DPLN), of which poor prognosis is indicated by aggravated renal function deterioration. However, the specific therapy and mechanisms of AKI in DPLN re...
| Published in: | Renal Failure |
|---|---|
| Main Authors: | Jianfen Zhu, Yijing Chen, Yulan Chen, Yinqiu Lv, Tianxin Chen |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2358187 |
Similar Items
Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis
by: Shuzo Sato, et al.
Published: (2020-03-01)
by: Shuzo Sato, et al.
Published: (2020-03-01)
DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
by: Liu Xingzhong, et al.
Published: (2023-07-01)
by: Liu Xingzhong, et al.
Published: (2023-07-01)
Receptor interacting protein kinase 1 activation and triggering mesangial cells necroptosis in MRL/lpr mice model of lupus nephritis
by: Lin Peng, et al.
Published: (2025-12-01)
by: Lin Peng, et al.
Published: (2025-12-01)
Angiopoietin-like 4 (ANGPTL4) Suppression Ameliorates Lupus Nephritis in MRL/lpr Mice by Inactivating NLRP3 Inflammasome and Inhibiting Inflammatory Response
by: Dan Luo, et al.
Published: (2023-09-01)
by: Dan Luo, et al.
Published: (2023-09-01)
Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
by: Young-Eun Kim, et al.
Published: (2023-09-01)
by: Young-Eun Kim, et al.
Published: (2023-09-01)
Rapamycin relieves lupus nephritis by regulating TIM-3 and CD4+CD25+Foxp3+ Treg cells in an MRL/lpr mouse model
by: Yan-fang Gao, et al.
Published: (2022-09-01)
by: Yan-fang Gao, et al.
Published: (2022-09-01)
Noninvasive Quantitative Evaluation of Proliferative Lupus Nephritis Based on Ultrasonic Viscoelastic Imaging
by: Yuan H, et al.
Published: (2025-03-01)
by: Yuan H, et al.
Published: (2025-03-01)
Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01)
by: Ala Ali, et al.
Published: (2013-01-01)
Tubulointerstitial nephritis in cases of lupus nephritis: An experience from a tertiary care referral center of Eastern India
by: Keya Basu, et al.
Published: (2022-09-01)
by: Keya Basu, et al.
Published: (2022-09-01)
Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis
by: Muhammed Mubarak
Published: (2013-01-01)
by: Muhammed Mubarak
Published: (2013-01-01)
Long-term renal outcomes of patients with non-proliferative lupus nephritis
by: Eun-Song Kang, et al.
Published: (2023-09-01)
by: Eun-Song Kang, et al.
Published: (2023-09-01)
Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice
by: Haruki Watanabe, et al.
Published: (2017-09-01)
by: Haruki Watanabe, et al.
Published: (2017-09-01)
Combined Network Pharmacology, Transcriptomics and Metabolomics Strategies Reveal the Mechanism of Action of Lang Chuang Wan to Ameliorate Lupus Nephritis in MRL/lpr Mice
by: Cuicui Li, et al.
Published: (2025-06-01)
by: Cuicui Li, et al.
Published: (2025-06-01)
Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation
by: Leran Chen, et al.
Published: (2023-12-01)
by: Leran Chen, et al.
Published: (2023-12-01)
A Preliminary Predictive Model for Proliferative Lupus Nephritis in Juvenile Systemic Lupus Erythematosus
by: Sern Chin Lim, et al.
Published: (2023-02-01)
by: Sern Chin Lim, et al.
Published: (2023-02-01)
Abemaciclib-associated acute interstitial nephritis successfully treated with glucocorticoids: a case report and literature review
by: Mari Kumano, et al.
Published: (2025-09-01)
by: Mari Kumano, et al.
Published: (2025-09-01)
Expression of B-cell activating factor (BAFF) in proliferative lupus nephritis, revisited
by: Asmaa Beltagy, et al.
Published: (2024-12-01)
by: Asmaa Beltagy, et al.
Published: (2024-12-01)
Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis
by: Marta Calatroni, et al.
Published: (2025-03-01)
by: Marta Calatroni, et al.
Published: (2025-03-01)
A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
by: Dong-Ni Chen, et al.
Published: (2018-01-01)
by: Dong-Ni Chen, et al.
Published: (2018-01-01)
Correlation between dyslipidemia and disease activity of lupus nephritis
by: Hu Hong-tu, et al.
Published: (2021-01-01)
by: Hu Hong-tu, et al.
Published: (2021-01-01)
Karyomegalic interstitial nephritis as a rare cause of kidney graft dysfunction: case report and review of literature
by: Fatma El-Husseiny Moustafa, et al.
Published: (2023-05-01)
by: Fatma El-Husseiny Moustafa, et al.
Published: (2023-05-01)
USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)
Reduced Renal CSE/CBS/H2S Contributes to the Progress of Lupus Nephritis
by: Xuan Wang, et al.
Published: (2023-02-01)
by: Xuan Wang, et al.
Published: (2023-02-01)
Outcome of proliferative lupus nephritis with thrombotic microangiopathy; An ambispective observational single-center study
by: Ahmed Fayed, et al.
Published: (2025-05-01)
by: Ahmed Fayed, et al.
Published: (2025-05-01)
Lupus Nephritis and Dysbiosis
by: Marta Monticolo, et al.
Published: (2023-04-01)
by: Marta Monticolo, et al.
Published: (2023-04-01)
DNase I alleviates renal inflammatory injury in MRL/lpr mice by inhibiting NETs formation
by: Manling Zhang, et al.
Published: (2025-10-01)
by: Manling Zhang, et al.
Published: (2025-10-01)
Current and Emerging Therapy on Lupus Nephritis
by: Lucky Aziza Bawazier
Published: (2018-01-01)
by: Lucky Aziza Bawazier
Published: (2018-01-01)
Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
by: Hussein A. Nasir, et al.
Published: (2014-01-01)
by: Hussein A. Nasir, et al.
Published: (2014-01-01)
Expression and clinical significance of NGAL/NGALR in lupus nephritis
by: ZENG Xing-ruo, et al.
Published: (2017-01-01)
by: ZENG Xing-ruo, et al.
Published: (2017-01-01)
Effect of renal interstitial vascular lesions on clinical pathological features and outcomes of lupus nephritis
by: HU Ai-xia, et al.
Published: (2019-01-01)
by: HU Ai-xia, et al.
Published: (2019-01-01)
Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice
by: Huimeng Qi, et al.
Published: (2023-10-01)
by: Huimeng Qi, et al.
Published: (2023-10-01)
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01)
by: Marlene Plüß, et al.
Published: (2022-11-01)
Clinical significance of urine hepcidin in lupus nephritis
by: TANG Dai-rong, et al.
Published: (2017-01-01)
by: TANG Dai-rong, et al.
Published: (2017-01-01)
Lupus nephritis – modern aspects of diagnosis and therapy. Part I
by: S. K. Solovyev, et al.
Published: (2024-03-01)
by: S. K. Solovyev, et al.
Published: (2024-03-01)
Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)
Literature review and case study of predominant tubulointerstitial lupus nephritis
by: Jun Wang, et al.
Published: (2025-12-01)
by: Jun Wang, et al.
Published: (2025-12-01)
Management of Lupus Nephritis
by: Merkel F, et al.
Published: (2000-01-01)
by: Merkel F, et al.
Published: (2000-01-01)
Pediatric lupus nephritis
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2018-11-01)
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2018-11-01)
Case of Granulomatous Interstitial Nephritis with Mediastinal Lymphadenopathy
by: Atul Kumar Srivastava, et al.
Published: (2025-07-01)
by: Atul Kumar Srivastava, et al.
Published: (2025-07-01)
Bioinformatics analysis of gene expression microarray in lupus nephritis
by: JIANG Qiu-zhu, et al.
Published: (2020-01-01)
by: JIANG Qiu-zhu, et al.
Published: (2020-01-01)
Similar Items
-
Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis
by: Shuzo Sato, et al.
Published: (2020-03-01) -
DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
by: Liu Xingzhong, et al.
Published: (2023-07-01) -
Receptor interacting protein kinase 1 activation and triggering mesangial cells necroptosis in MRL/lpr mice model of lupus nephritis
by: Lin Peng, et al.
Published: (2025-12-01) -
Angiopoietin-like 4 (ANGPTL4) Suppression Ameliorates Lupus Nephritis in MRL/lpr Mice by Inactivating NLRP3 Inflammasome and Inhibiting Inflammatory Response
by: Dan Luo, et al.
Published: (2023-09-01) -
Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
by: Young-Eun Kim, et al.
Published: (2023-09-01)
